G Protein News and Research

RSS

New study may allow scientists to develop screening test for idiopathic pulmonary fibrosis

A simple blood test could predict which patients with the lung-scarring disease known as idiopathic pulmonary fibrosis (IPF) are soon to get far worse, an indicator that could one day influence their treatment, according to researchers at the University of Pittsburgh School of Medicine.

4 Feb 2010

Scientists identify potential drug therapy target for malaria

Scientists at Washington University School of Medicine in St. Louis have identified a protein made by the malaria parasite that is essential to its ability to take over human red blood cells.

4 Feb 2010

New discovery lays foundation for development of new anti-HIV drugs

A team of scientists at The Scripps Research Institute has identified two compounds that act on novel binding sites for an enzyme used by the human immunodeficiency virus (HIV), the virus that causes AIDS.

4 Feb 2010

Health Discovery receives final patent infringement payment from Vermillion

Health Discovery Corporation announced today that the Company has received the final payment that was due under the agreement that settled the Company’s patent infringement lawsuit against Vermillion, formerly known as Ciphergen Biosystems, Inc.

4 Feb 2010

Researchers develop simple urine test to predict and diagnose preeclampsia

Researchers at Yale School of Medicine have developed a simple urine test to rapidly predict and diagnose preeclampsia, a common, but serious hypertensive complication of pregnancy.

4 Feb 2010

Study on the role of MCP-1 in obese patients with pancreatic cancer

The levels of an inflammatory chemokine were significantly elevated in patients with pancreatic cancer who were extremely obese, according to research conducted by scientists at the Jefferson Pancreatic, Biliary and Related Cancers Center. They presented their data at the 5th Annual Academic Surgical Congress, held in San Antonio.

4 Feb 2010

Anti-inflammatory plant derivative could play a role in cancer treatment, say MCG researchers

Medical College of Georgia researchers are seeking to refine cancer treatment with an anti-inflammatory plant derivative long used in Chinese medicine.

4 Feb 2010

UTMB: Mother's exposure to BPA increases risks of asthma in her children

For years, scientists have warned of the possible negative health effects of bisphenol A, a chemical used to make everything from plastic water bottles and food packaging to sunglasses and CDs.

4 Feb 2010

Study could lead to non-surgical alternatives for tonsillectomies

Children with obstructive sleep apnea (OSA) may one day be able to have an injection or use a throat spray instead of getting their tonsils removed to cure their snoring, according to a new study from the University of Chicago, which found that a specific gene product may be responsible for the proliferation of adenotonsillar tissue that can cause pediatric OSA.

4 Feb 2010

Prolactin reduces the levels of BCL6 protein and prevents aggressive breast cancer

Researchers from the Kimmel Cancer Center at Jefferson have found a mechanism by which a hormone responsible for milk production blocks an oncogene that makes breast cancer more aggressive.

4 Feb 2010

Repligen receives USPTO Notice of Allowance for patent covering a recombinant form of Protein A

Repligen Corporation announced today that it has received a Notice of Allowance from the United States Patent and Trademark Office for a patent covering a recombinant form of Protein A which is identical in structure to the commercial form of Protein A from Staphylococcus aureus which is used in the production of many of the world's approved monoclonal antibodies. The patent, which will remain in force until 2028, covers a new Repligen proprietary product which is now available in commercial quantities.

4 Feb 2010

New vaccine to prevent malaria infection shown promise to protect young children

A new vaccine to prevent the deadly malaria infection has shown promise to protect the most vulnerable patients - young children - against the disease, according to an international team of researchers led by the University of Maryland School of Medicine's Center for Vaccine Development (CVD) and the Malaria Research and Training Center at the University of Bamako in Mali, West Africa.

4 Feb 2010

Phase 2a clinical trial results of VX-809 in patients with CF announced

Vertex Pharmaceuticals Incorporated today announced results from a preliminary analysis of data from a 28-day Phase 2a clinical trial of VX-809 in patients with cystic fibrosis (CF) who are homozygous for the F508del mutation.

4 Feb 2010

BRAF drugs may accelerate tumour growth in cancer patients with faulty RAS gene

A team of UK scientists has made the unexpected discovery that drugs which target a well known fault in a protein called BRAF could actually fuel the progression of cancer in some cases. The findings of this study, which was jointly funded by Cancer Research UK, The Institute of Cancer Research (ICR) and the Wellcome Trust are published in Cell.

3 Feb 2010

Bionanomotors can be used some day to move and manipulate molecules at nanoscale

A group of Marshall University researchers and their colleagues in Japan are conducting research that may lead to new ways to move or position single molecules-a necessary step if man someday hopes to build molecular machines or other devices capable of working at very small scales.

3 Feb 2010

Pall launches PallSep Biotech filtration system

Pall Corporation, a global leader in filtration, separation and purification, has introduced the PallSep Biotech system for the gentle separation of target molecules from complex biotechnology process fluids.

From Pall Corporation 3 Feb 2010

Patients with high levels of proteinuria have increased risk of all-cause death

Patients with high levels of proteinuria (protein in urine) in addition to another marker of reduced kidney function had an associated increased risk of all-cause death, heart attack or progression to kidney failure, according to a study in the February 3 issue of JAMA.

3 Feb 2010

Promising results from Soligenix' RiVax vaccine trials against ricin toxin

Soligenix, Inc., a late-stage biotechnology company, announced today the publication of an article in the February 2010 edition of Vaccine, which describes preclinical formulations of RiVax™, its ricin toxin vaccine, with heightened stability. The article was authored by the Company's collaborators at the University of Texas Southwestern Medical Center at Dallas (UT Southwestern) where the vaccine originated. RiVax™ is currently being evaluated in Phase 1 human safety and immunogenicity trials, as well as non-human primate trials for efficacy.

3 Feb 2010

MaxMuscleMass.com: Save up to 40% off the retail prices in body building supplement retail stores

MaxMuscleMass.com, an online body building supplement store, wants you to save up to 40% off the retail prices found in gyms and body building supplement retail stores.

3 Feb 2010

Researchers find three different degenerative brain disorders linked by toxic form of Elk-1 protein

For the first time, researchers from the University of Pennsylvania School of Medicine have found that three different degenerative brain disorders are linked by a toxic form of the same protein. The protein, called Elk-1, was found in clumps of misshaped proteins that are the hallmarks of Parkinson's disease, Alzheimer's disease, and Huntington's disease.

3 Feb 2010

G Protein News and Research

New study may allow scientists to develop screening test for idiopathic pulmonary fibrosis

Scientists identify potential drug therapy target for malaria

New discovery lays foundation for development of new anti-HIV drugs

Health Discovery receives final patent infringement payment from Vermillion

Researchers develop simple urine test to predict and diagnose preeclampsia

Study on the role of MCP-1 in obese patients with pancreatic cancer

Anti-inflammatory plant derivative could play a role in cancer treatment, say MCG researchers

UTMB: Mother's exposure to BPA increases risks of asthma in her children

Study could lead to non-surgical alternatives for tonsillectomies

Prolactin reduces the levels of BCL6 protein and prevents aggressive breast cancer

Repligen receives USPTO Notice of Allowance for patent covering a recombinant form of Protein A

New vaccine to prevent malaria infection shown promise to protect young children

Phase 2a clinical trial results of VX-809 in patients with CF announced

BRAF drugs may accelerate tumour growth in cancer patients with faulty RAS gene

Bionanomotors can be used some day to move and manipulate molecules at nanoscale

Pall launches PallSep Biotech filtration system

Patients with high levels of proteinuria have increased risk of all-cause death

Promising results from Soligenix' RiVax vaccine trials against ricin toxin

MaxMuscleMass.com: Save up to 40% off the retail prices in body building supplement retail stores

Researchers find three different degenerative brain disorders linked by toxic form of Elk-1 protein

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News